Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article


BioSpace???s Favorite FDA Tricks Or Treats

Tug-Of-War Over Revlimid Patent Continues Between Celgene, Natco Pharma Limited

Amgen Lays Off 274 Employees As Part Of Its Exit From Washington State

How Regeneron Is Benefiting From Continued Sanofi Investments

Ten Men For Every Woman Present In Biotech Boardrooms: Reports

Sunshine May Slow Weight Gain And Diabetes Onset, University of Edinburgh Study

Pfizer's $11 Billion Buyback Dims Prospects Of AstraZeneca PLC Bid

Shire Stands To Grab $1.6B From AbbVie In Third Largest Breakup Fee In History

New Actavis CEO Has $70 Billion In Deals To Choose From

Herbal Medicines Could Contain Dangerous Levels Of Toxic Mold,

Gene That Once Aided Survival In The Arctic Found To Have Negative Impact On Health Today, University of Cambridge Study

Omega 3 Can Help Children With ADD, University of Gothenburg Study

Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc., Says Analyst

Science Confirms Occasional Weed Use Doesn't Lower Your IQ, University College London Study

Billionaire Pledges $100 Million To Fight Ebola

Five Prime Therapeutics, Inc. Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline

Baxter International, Inc.'s Hemophilia A Drug Obizur Wins FDA Approval

New AbbVie Head Blasts Canada???s Patent Laws On Drugs

Hikma Pharmaceuticals Falls On FDA Warning For Portugal Plant

FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc.'s Natpara

KeraNetics, LLC Quadrupling Manufacturing Space With Plan To Move Into Targacept, Inc.'s Old Haunts

AstraZeneca PLC's Cancer Drug Pipeline Gets Boost From European Green Light

Genmab A/S Banks $10 Million Milestone Payment From Janssen Biotech Inc.

QLT Inc. Appoints As Interim CEO

Top 30 Life Science Startups To Watch In The U.S.

Drugmakers Like GlaxoSmithKline May Need Compensation For Fast-Tracked Ebola Vaccines

Johnson & Johnson To Launch Incubator At Houston???s To Boost Biotechs

SF Wants Pharma To Pay For A Take-Back Program; Who's Next?

Biogen Idec Slumps After Patient On Top-Selling Drug Dies

Eli Lilly And Luminex Exclusive: Straight Talk From Career Experts On How To Get Hired

Ocera Therapeutics, Inc.???s New HE Drug Could Pull Stock Up Out Of Rut: Cowen

Actavis Takes Axe To Forest Laboratories, Inc. Again; Cuts 100 Jobs In New York

Celgene Beats The Street Again On Earnings And Analysts Couldn???t Be Happier

SSF's Sutro Biopharma Forges $1 Billion+ And Option To Buy Pact With Celgene

Ebola Clinical Trials: Big Name Players In The Ebola Race

Activist Investor Urges Amgen To Break Up

New Role Created At GlaxoSmithKline's Vaccines Unit

Novartis AG's AIN457 Meets Primary Endpoint In Two Late Stage Studies

New Startup Snags $17 Million From Pfizer And Novartis AG

Mylan Inc., Abbott Laboratories Tweak $5 Billion Tax Inversion Deal

ERYtech Pharma Successfully Snags €30 Million

Eli Lilly Adds $375 Million To Zymeworks Partnership

If You???re Over 60, Drink Up: Alcohol Associated With Better Memory, University of Texas Study

Job Cuts Loom Over GlaxoSmithKline As It Aims To Cut Costs; Eyes IPO Of HIV Unit

Cash Receipts Account For High BPA Levels In Humans, University of Missouri Study

Ablynx's Ant-Il-6R Nanobody Partnered With AbbVie Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection

Trinity Biotech Temporary Suspends Meritas Troponin Trials

AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. As CEO

Revealed: Pharaoh Suffered Several Afflictions Because His Parents Were Brother And Sister

NIH Begins Early Human Clinical Trial Of VSV Ebola Vaccine

Gilead Sciences, Inc. To Create More Than 80 Jobs With $50 Million Expansion

Finally: A Missing Link Between Vitamin D and Prostate Cancer, University of Colorado Study

Frozen Embryos Produce More Confident Babies, Study

High-Fat Meals Could Be More Harmful To Males Than Females, Cedars-Sinai Medical Center Reveals

Scientific Evidence Does Not Support The Brain Game Claims, Stanford University Scholars Say

Flu Vaccine May Hold Key To Preventing Heart Disease, Study

Walnuts May Help Protect Against Alzheimer???s Disease, Reveals

Y Chromosome Linked To Cancer And Death Risk In Men, Uppsala Universitet Study

Vertex Pharmaceuticals (MA) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion

Woman Finds Three-Inch Leech In Nose After South East Asia Trip

Roche To Spend $3.2 Billion On Basel Site Upgrade

Recalled Dietary Supplements Found To Still Contain Banned Substances

Hold Your Horses On Splicing Amgen, Say Citi Analysts

GlaxoSmithKline, Johnson & Johnson Join Forces To Make Millions Of Ebola Vaccine Doses

Regulus Therapeutics, Inc. Gets Seat At Hepatitis C Table With Impressive Phase 1 Results; Stock Up 99.98% At 12:54PM ET On Wednesday

What Happens When Chemists Don't Wash Their Hands

Viamet Pharmaceuticals Withdraws $75 Million IPO, Spins Off Cancer Program To Form

Lexicon Pharmaceuticals, Inc., Ipsen Strike Licensing Deal Worth $145 Million

Forendo Pharma Closes EUR 12 Million Series A Financing Round

Actavis Pays $40 Million Upfront; Snags Option To Buy

Johnson & Johnson Pledges $200 Million To Ebola, Will Begin Testing Vaccine In January 2015

AcelRx Pharmaceuticals's Zalviso Met Primary Endpoint In Phase 3 Study

FDA Panel Unanimously Backs Novartis AG' Psoriasis Drug

Sucampo Pharmaceuticals, Inc., Takeda Forge $55 Million Deal For Amitiza®

GlaxoSmithKline's Rising Star Under Pressure As Drugs Falter

Boston's Proteon Therapeutics, Inc. Files For $61 Million IPO

Shift Workers Might Want To Skip High-Iron Foods At Night, University of Utah Study

Brain Scans Show Cause Of Seasonal Affective Disorder, University of Copenhagen Study

Cold Sore Virus Increases The Risk Of Dementia, Umea University Study

For Infertility Treatment, Should He Drink Less Coffee, More Booze? Harvard School of Public Health Study

Number Of Eggs A Woman Has Predicts Heart Attack Risk, University of California, San Francisco (UCSF) Study

Birth Season Affects Your Mood In Later Life, Semmelweis University Study

Should We Allow Scientists To Create Super-Viruses?

Actavis Will Compete With Sanofi For $5.1 Billion Omega Pharma NV Deal

New Biotech, Launches In Cambridge With $12 Million In Pocket

Vericel, An Old Genzyme Corporation Business, Quietly Gets New Life And Space In Cambridge

Viamet Pharmaceuticals Reels In $60 Million Series D Financing

Aspirin Shown To Benefit Schizophrenia Treatment, University Medical Center Utrecht Study

ISI Group: AbbVie???s Dividend, Repurchasing Attempt Could Mean More Debt

AbbVie Officially Abandons

Enanta Pharmaceuticals, Inc. Rejects HCV Drug Co-Development Option With AbbVie

Allergan Inc. Chops Jobs In Carlsbad

Omeros Corporation Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday

GlycoMimetics, Inc. Signs A Long Term Lease For A Bigger Space In Maryland

Genentech, NewLink Genetics Strike $1 Billion+ Cancer Deal

Biotech Startup Factory PureTech Nabs $55 Million

David And Barbara Roux Provide Historic $10 Million Gift To Advance Genomic Medicine Research At The Jackson Laboratory

Despite Conflicting Data, Cytokinetics, Inc. Plans To Take ALS Drug Into Late Stage Study

Rho Awarded New Federal Contract From

Analysts Predict FDA Approval Of Novo Nordisk A/S's Obesity Drug By Year-End

Lupin Ltd. Scouts For Acquisitions In U.S.

Fab'entech: Committed To Fight Emerging Infectious Diseases

Valeant Hints At Higher Bid For Allergan Inc.

AstraZeneca PLC, Bristol-Myers Squibb Company Won???t Have To Face Kickback Lawsuit

Gilead Sciences, Inc.'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons

Shire Goes Shopping After AbbVie Deal Falls Through

Celgene???s New Crohn???s Disease Drug Impressing Analysts

Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study

Parkinson???s Drugs Linked To Impulse Control Disorders, Study

Panic Attacks Associated With Fear Of Bright Daylight, University of Siena Study

Oh, Brother! Having A Sibling Makes Boys Selfless, Brigham Young University Study

Why Depression And Aging Boost Disease Risk, Reveals

Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC

Current Climate The Best For Biotech IPOs In Decades, Says VC

Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist

Don't Blame CDC Chief For Ebola

Big Pharma Has An Interest In Rich People Being Sick

Shire's Finance Chief Jumps Ship

Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences In Deal Worth $305 Million

Amgen Will Assign 12 To 14 Staff Members To Look Into An Alternative Production Method For Mapp Biopharmaceutical's ZMapp

TesoRx, Ink $95 Million Pact

Cubist Pharmaceuticals, Inc. Brings In Ex-Biogen Idec Exec For CEO Post

Regeneron's EYLEA?? Tops Rivals In Study

Xenon Pharmaceuticals Inc. Postpones IPO

Ranbaxy Laboratories??? Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd Buyout


    Read more..